US6620406B1
(en)
|
1994-03-08 |
2003-09-16 |
Genetics Institute, Llc. |
Methods for treatment of periodontal diseases and lesions using bone morphogenetic proteins
|
US5626861A
(en)
*
|
1994-04-01 |
1997-05-06 |
Massachusetts Institute Of Technology |
Polymeric-hydroxyapatite bone composite
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5674292A
(en)
|
1995-06-07 |
1997-10-07 |
Stryker Corporation |
Terminally sterilized osteogenic devices and preparation thereof
|
CZ299025B6
(cs)
*
|
1996-02-09 |
2008-04-02 |
Amgen Inc. |
Farmaceutická kompozice a její použití
|
EP0852951A1
(de)
*
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
ZA9711580B
(en)
*
|
1996-12-25 |
1999-09-23 |
Hoechst Marion Roussel Ltd |
Process for the production of purified dimeric bone morphogenetic factors.
|
DE69814352T3
(de)
*
|
1997-02-07 |
2009-08-13 |
Stryker Corp., Kalamazoo |
Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
|
AU779278B2
(en)
*
|
1997-02-07 |
2005-01-13 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
US7041641B2
(en)
*
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
US6071982A
(en)
*
|
1997-04-18 |
2000-06-06 |
Cambridge Scientific, Inc. |
Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
|
AU7260598A
(en)
*
|
1997-04-28 |
1998-11-24 |
Trustees Of The University Of Pennsylvania, The |
Method for promoting myogenesis using osteogenic proteins
|
US6391336B1
(en)
*
|
1997-09-22 |
2002-05-21 |
Royer Biomedical, Inc. |
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
EP2374870B1
(en)
*
|
1998-10-06 |
2014-04-23 |
Stryker Corporation |
Composition comprising an osteogenic protein selected from the group consisting of OP-2, OP-3, BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-9, BMP-10, BMP-11, BMP-15, BMP-3B, DPP, Vg-1, Vgr-1, 60A protein, GDF-1, GDF-2, GDF-3, GDF-6, GDF-7, GDF-8, GDF-9, GDF-10, and GDF-11 for use in repairing a defect locus in nonarticular cartilage
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US7371408B1
(en)
*
|
1999-06-07 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US7052856B2
(en)
*
|
1999-10-05 |
2006-05-30 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
US7687462B2
(en)
*
|
1999-10-05 |
2010-03-30 |
The Regents Of The University Of California |
Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
|
US20090060988A1
(en)
*
|
1999-10-05 |
2009-03-05 |
Kang Ting |
Nell-1 enhanced bone mineralization
|
WO2006089023A2
(en)
|
2005-02-16 |
2006-08-24 |
The Regents Of The University Of California |
Pharmaceutical compositions for treating or preventing bone conditions
|
US7884066B2
(en)
*
|
1999-10-05 |
2011-02-08 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
WO2004024893A2
(en)
*
|
2002-09-13 |
2004-03-25 |
The Regents Of The University Of California |
Nell-1 enhanced bone mineralization
|
EP1155704A1
(en)
*
|
2000-01-13 |
2001-11-21 |
Chih-I Lin |
Orthopedic filling material and method of use thereof
|
US6630153B2
(en)
*
|
2001-02-23 |
2003-10-07 |
Smith & Nephew, Inc. |
Manufacture of bone graft substitutes
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
SE517168C2
(sv)
*
|
2000-07-17 |
2002-04-23 |
Bone Support Ab |
En komposition för ett injicerbart ersättningsmaterial för benmineral
|
US20080233165A1
(en)
*
|
2000-08-07 |
2008-09-25 |
Biolok International, Inc. |
Time release calcium sulfate and growth factor matrix for bone augmentation
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
TWI255272B
(en)
*
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
CA2447683A1
(en)
*
|
2001-04-16 |
2002-10-24 |
James J. Cassidy |
Dense/porous structures for use as bone substitutes
|
US20070254009A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic/bone morphogenic protein formulation and method of treatment
|
US20050129732A1
(en)
*
|
2001-07-13 |
2005-06-16 |
Flow Focusing, Inc. |
Biodegradable, antibiotic, controlled release tape
|
US20070254008A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US20060263401A1
(en)
*
|
2001-07-13 |
2006-11-23 |
Flow Focusing, Inc. |
Formulation and Method for Preventing Infection
|
US7371409B2
(en)
*
|
2001-09-06 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
BR0214275A
(pt)
*
|
2001-11-19 |
2004-09-21 |
Scil Technology Gmbh |
Dispositivo tendo propriedades osteocondutora e osteoindutora
|
EP1578348A4
(en)
*
|
2002-02-08 |
2011-03-16 |
Wyeth Llc |
FORMULATION WITH BIOACTIVE AGENTS AND METHOD OF USE THEREOF
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
EP1489998B1
(en)
*
|
2002-03-29 |
2010-12-08 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US6652887B1
(en)
|
2002-06-24 |
2003-11-25 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US7291179B2
(en)
*
|
2002-06-24 |
2007-11-06 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US20040002770A1
(en)
*
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
US7029006B2
(en)
*
|
2002-08-29 |
2006-04-18 |
Canon Kabushiki Kaisha |
Sheet feeding apparatus and image forming apparatus
|
US8986737B2
(en)
*
|
2002-09-05 |
2015-03-24 |
Wm. Marsh Rice University |
Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
|
ES2260685T3
(es)
*
|
2002-09-10 |
2006-11-01 |
Scil Technology Gmbh |
Implante metalico recubierto, a una concentracion de oxigeno reducida, con proteina osteoinductora.
|
AU2003286472A1
(en)
|
2002-10-17 |
2004-05-04 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
PL378571A1
(pl)
*
|
2003-02-01 |
2006-05-02 |
Neuralab Limited |
Czynna immunizacja dla wytworzenia przeciwciał przeciw rozpuszczalnemu A-ß
|
US7507257B2
(en)
*
|
2003-02-04 |
2009-03-24 |
Wright Medical Technology, Inc. |
Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects
|
DE602004032107D1
(de)
*
|
2003-02-07 |
2011-05-19 |
Univ California |
Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids
|
PE20050627A1
(es)
*
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
EP1638530A2
(en)
*
|
2003-06-20 |
2006-03-29 |
Royer Biomedical, INC. |
Drug polymer complexes
|
US20040262809A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Smith Todd S. |
Crosslinked polymeric composite for orthopaedic implants
|
WO2005037232A2
(en)
|
2003-10-17 |
2005-04-28 |
Joslin Diabetes Center, Inc. |
Methods and compositions for modulating adipocyte function
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20070231788A1
(en)
*
|
2003-12-31 |
2007-10-04 |
Keyvan Behnam |
Method for In Vitro Assay of Demineralized Bone Matrix
|
WO2005065396A2
(en)
|
2003-12-31 |
2005-07-21 |
Osteotech, Inc. |
Improved bone matrix compositions and methods
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
US8377904B2
(en)
*
|
2004-02-09 |
2013-02-19 |
Hill's Pet Nutrition, Inc. |
Composition and method for use in cartilage affecting conditions
|
US7691607B2
(en)
*
|
2004-02-09 |
2010-04-06 |
The Regents Of The University Of California |
Expression system of NELL peptide
|
ES2375802T3
(es)
|
2004-04-15 |
2012-03-06 |
Alkermes Pharma Ireland Limited |
Dispositivo de liberación sostenida a base de pol�?mero.
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8512738B2
(en)
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US7384430B2
(en)
*
|
2004-06-30 |
2008-06-10 |
Depuy Products, Inc. |
Low crystalline polymeric material for orthopaedic implants and an associated method
|
JP2008505978A
(ja)
*
|
2004-07-12 |
2008-02-28 |
アラーガン、インコーポレイテッド |
眼病用組成物および眼病治療法
|
EP3698780A1
(en)
*
|
2004-08-09 |
2020-08-26 |
Enrique Melendez Hevia |
Glycine as a diet supplement for use in the prevention and/or treatment of an infectious disease caused by a virus in a human in the need of promoting the synthesis of collagen
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US7250550B2
(en)
*
|
2004-10-22 |
2007-07-31 |
Wright Medical Technology, Inc. |
Synthetic bone substitute material
|
US7625560B2
(en)
*
|
2004-12-15 |
2009-12-01 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US8916165B2
(en)
*
|
2004-12-15 |
2014-12-23 |
Janssen Alzheimer Immunotherapy |
Humanized Aβ antibodies for use in improving cognition
|
PE20061401A1
(es)
*
|
2004-12-15 |
2006-12-23 |
Neuralab Ltd |
ANTICUERPOS Aß PARA MEJORAR LA COGNICION
|
US7883653B2
(en)
|
2004-12-30 |
2011-02-08 |
Depuy Products, Inc. |
Method of making an implantable orthopaedic bearing
|
US7896921B2
(en)
*
|
2004-12-30 |
2011-03-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
US7879275B2
(en)
*
|
2004-12-30 |
2011-02-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
TW200638943A
(en)
*
|
2005-01-28 |
2006-11-16 |
Wyeth Corp |
Stabilized liquid polypeptide formulations
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
CA2602419A1
(fr)
*
|
2005-02-24 |
2006-08-31 |
Roland Dricot |
Implant osseux
|
US20100150885A1
(en)
|
2005-06-01 |
2010-06-17 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US20060286171A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Tianhong Zhou |
Bone morphogenetic protein formulations
|
EP1933892B1
(en)
*
|
2005-09-09 |
2012-12-12 |
Wright Medical Technology, Inc. |
Composite bone graft substitute cement and articles produced therefrom
|
US8025903B2
(en)
*
|
2005-09-09 |
2011-09-27 |
Wright Medical Technology, Inc. |
Composite bone graft substitute cement and articles produced therefrom
|
AU2006308534B2
(en)
*
|
2005-11-01 |
2013-02-07 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
WO2007136664A2
(en)
*
|
2006-05-16 |
2007-11-29 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
DK2049040T3
(en)
*
|
2006-07-21 |
2015-06-29 |
Genera Istrazivanja D O O |
Whole blood derived coagulum device for the treatment of bone defects
|
US8101198B2
(en)
*
|
2006-07-26 |
2012-01-24 |
The Regents Of The University Of California |
Osteogenic enhancer composition
|
US20080051796A1
(en)
*
|
2006-08-01 |
2008-02-28 |
Warsaw Orthopedic, Inc. |
Graft retention tack
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
DE102006060958A1
(de)
*
|
2006-12-20 |
2008-06-26 |
Jennissen, Herbert P., Prof. Dr. |
Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
|
JP2010522196A
(ja)
*
|
2007-03-22 |
2010-07-01 |
アルカームズ,インコーポレイテッド |
コアセルベーション工程
|
KR20100016661A
(ko)
*
|
2007-04-18 |
2010-02-12 |
얀센 알츠하이머 이뮤노테라피 |
대뇌 아밀로이드 혈관병증의 예방 및 치료
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
PT2157967E
(pt)
|
2007-04-23 |
2013-04-03 |
Intarcia Therapeutics Inc |
Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
|
EP2144624A1
(en)
*
|
2007-05-15 |
2010-01-20 |
Stryker Corporation |
Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
|
CA2690816C
(en)
*
|
2007-06-15 |
2016-12-06 |
Osteotech, Inc. |
Method of treating tissue
|
EP2167147B1
(en)
|
2007-06-15 |
2017-03-29 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
WO2008157492A2
(en)
|
2007-06-15 |
2008-12-24 |
Osteotech, Inc. |
Osteoinductive demineralized cancellous bone
|
US9554920B2
(en)
*
|
2007-06-15 |
2017-01-31 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions having nanoscale textured surfaces
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
WO2009009688A1
(en)
|
2007-07-10 |
2009-01-15 |
Osteotech, Inc. |
Delivery system
|
US20110054408A1
(en)
*
|
2007-07-10 |
2011-03-03 |
Guobao Wei |
Delivery systems, devices, tools, and methods of use
|
PL2182983T3
(pl)
|
2007-07-27 |
2014-10-31 |
Janssen Alzheimer Immunotherap |
Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
|
EP2187932B1
(en)
*
|
2007-08-07 |
2015-01-28 |
DePuy Synthes Products, LLC |
Protein formulations comprising gdf-5 in aqueous acidic solution
|
JO3076B1
(ar)
*
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
CA2702499A1
(en)
|
2007-10-19 |
2009-04-23 |
Osteotech, Inc. |
Demineralized bone matrix compositions and methods
|
DE102007051914A1
(de)
*
|
2007-10-29 |
2009-05-07 |
Herbert Prof. Dr. Jennissen |
Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
CA2720845A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered gdf-5 formulations
|
US9616153B2
(en)
*
|
2008-04-17 |
2017-04-11 |
Warsaw Orthopedic, Inc. |
Rigid bone graft substitute
|
US20110104133A1
(en)
*
|
2008-05-06 |
2011-05-05 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US9492375B2
(en)
*
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
WO2010093950A1
(en)
*
|
2009-02-12 |
2010-08-19 |
Osteotech, Inc. |
Delivery system cartridge
|
CN102448983A
(zh)
|
2009-05-26 |
2012-05-09 |
加州大学董事会 |
纤调蛋白肽
|
KR102148624B1
(ko)
|
2009-09-28 |
2020-08-26 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
KR101769637B1
(ko)
|
2009-11-09 |
2017-08-18 |
알러간, 인코포레이티드 |
모발 성장을 촉진하기 위한 조성물 및 방법
|
WO2011086788A1
(ja)
*
|
2010-01-15 |
2011-07-21 |
国立大学法人島根大学 |
骨セメント
|
US9180137B2
(en)
|
2010-02-09 |
2015-11-10 |
Bone Support Ab |
Preparation of bone cement compositions
|
CN102858278B
(zh)
*
|
2010-04-29 |
2016-08-17 |
华沙整形外科股份有限公司 |
可流动陶瓷胶泥
|
ES2911190T3
(es)
|
2010-05-11 |
2022-05-18 |
Howmedica Osteonics Corp |
Compuestos organofosforados, de metales multivalentes y composiciones y métodos de red interpenetrantes adhesivos poliméricos
|
EP2606121B1
(en)
|
2010-08-19 |
2016-05-11 |
The Regents of The University of California |
Compositions comrpising perivascular stem cells and nell-1 protein
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
JP6224579B2
(ja)
|
2011-04-11 |
2017-11-01 |
インデュース バイオロジクス インコーポレイテッドInduce Biologics Inc. |
増殖因子の多相放出を行うためのシステムおよび方法
|
US8765189B2
(en)
|
2011-05-13 |
2014-07-01 |
Howmedica Osteonic Corp. |
Organophosphorous and multivalent metal compound compositions and methods
|
CN104220046A
(zh)
|
2012-04-11 |
2014-12-17 |
感应生物制品股份有限公司 |
用于生长因子多相释放的体系和方法
|
KR20150119254A
(ko)
|
2013-02-15 |
2015-10-23 |
알러간, 인코포레이티드 |
지속된 약물 전달 임플란트
|
PL2958603T3
(pl)
|
2013-02-20 |
2018-10-31 |
Bone Support Ab |
Ulepszone zestalanie utwardzalnego materiału zastępczego kości
|
TWI651103B
(zh)
|
2013-12-13 |
2019-02-21 |
萊特醫技股份有限公司 |
多相骨移植替代材料
|
AU2015233396B2
(en)
|
2014-03-20 |
2020-01-30 |
Stayble Therapeutics Ab |
A composition for use in the treatment of intervertebral disc-related pain
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CA2977625A1
(en)
*
|
2014-12-29 |
2016-07-07 |
Bioventus, Llc |
Systems and methods for improved delivery of osteoinductive molecules in bone repair
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
BR112018008388A2
(pt)
|
2015-10-30 |
2018-10-23 |
Bioventus Llc |
composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso
|
CN109310743A
(zh)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
胰高血糖素受体选择性多肽及其使用方法
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
EP3468626A1
(en)
|
2016-06-10 |
2019-04-17 |
Bioventus LLC |
Protein delivery with porous metallic structure
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|